SEATTLE – Is proteomics ready to stop beating itself up and proceed to the next phase?
At last week’s American Association for Clinical Chemistry’s conference on translating proteomics from discoveries into diagnostics, presenters focused less on beating up on themselves for past setbacks and more on figuring out how to move past their shortcomings to create a genuine clinical pipeline.